@FiercePharma: Oncologists lament growing drug shortages. Report | Follow @FiercePharma
> The amount Spain's public hospitals owe drug companies rose 11 percent to €5.12 billion ($7.5 billion) in the first quarter of 2011, industry association Farmaindustria said. Story
> FDA has postponed a ruling on a citizens petition from Teva Pharmaceutical Industries seeking to prevent the launch of generic versions of its multiple sclerosis drug Copaxone. Article
> Abbott Laboratories hopes a recent leadership change atop its nutrition business will spur improved profitability, which has lagged that of rival Mead Johnson Nutrition. Report
> Somaxon Pharmaceuticals has tapped Paladin Labs to market the sleep treatment Silenor in Canada, South America and Africa. Release
> Impax Laboratories shares dropped 11 percent in early trading Wednesday after analysts at J.P. Morgan cut their rating of the stock to neutral from overweight. Article
> Europe's pharmaceutical industry has warned that a review of E.U. law could undermine the pricing and reimbursement of medicines. Item
Biotech News
@FierceBiotech: What's in a (drug) name? Article | Follow @FierceBiotech
@JohnCFierce: Still early days on the Ph2 Vertex program. CFF CEO talks about "important new information about the potential to address the basic defect." | Follow @JohnCFierce
> Polaris chief balances woes with pros of biotech investing. Report
> Selecta teams with diabetes foundation on Type 1 vaccine. Article
> Vertex shares slide as CF drug combo raises questions in Ph2. Story
> Pfizer unveils $100M Boston effort to spark R&D innovation. Report
Pharma Manufacturing News
> Novartis leans on CMOs for ops gains. Article
> HP primed for large-scale track/trace. Report
> Disposables maker goes solar, targeting energy costs. Story
> Glass chips prompt another American Regent recall. Item
> India yanks license of uncooperative Chinese supplier. News
> Sun, Max RFID pilot advances. Report
Vaccine News
> Adult vaccines cut down on healthcare costs. Article
> UCFS researchers unveil promising glioblastoma vaccine data. Report
> Vaccine makers cut prices for developing countries. Story
> J&J, GSK team on malaria vaccine. Article
> Vaxart starts Ph1 oral vax trial. Item
And Finally... Lower cholesterol and blood pressure levels helped cut the risk of having a heart attack in the U.K. by 74 percent over two decades, though rising obesity rates may undermine that progress, researchers said. Report